The resolution introduced in the Wisconsin Legislature designates June 2025 as Myasthenia Gravis Awareness Month. Myasthenia gravis (MG) is an autoimmune neuromuscular disease characterized by chronic muscle weakness due to antibodies attacking muscle receptors, leading to symptoms such as blurred vision, speech impairment, and difficulty swallowing. The resolution highlights the challenges in diagnosing MG, as its symptoms can overlap with other disorders, and emphasizes the importance of timely healthcare interventions to prevent severe complications.

The resolution is supported by a bipartisan group of representatives and senators and aims to raise awareness about MG, which affects approximately 10 to 20 out of every 100,000 Americans. By designating June as Myasthenia Gravis Awareness Month, the resolution seeks to unite the MG community in Wisconsin and promote understanding of the condition, its impact on individuals, and the available support resources.